This investigation of maternal and child risk factors for IDA was approved by the University of Wisconsin and Meriter Institutional Review Boards. English and Spanish speaking women, 18-40 years of age, delivering newborns ≥35 weeks of gestation at Meriter Hospital were eligible to participate. Consent was obtained from those with ≥1 medical or demographic risk factors for depleted newborn or infant iron status, including prenatally diagnosed maternal IDA, pre-gestational or gestational diabetes mellitus, SGA or LGA newborns, maternal ethnic minority (African-American, Latina or Asian), or low socioeconomic status, using the surrogate of self-pay or Medicaid. Specimens from a total of 309 newborns with 1 or more risk factors were analyzed. Although not a previously reported risk factor nor criterion for enrollment, we included maternal BMI >30 kg/m2 as a risk factor in our analysis is because it predisposes to maternal IDA, gestational diabetes, and fetal overgrowth, all risk factors for depletion of newborn iron stores. To provide a reference comparison, we generated cord blood laboratory data from a recent representative population of 188 healthy newborns born at ≥35 weeks of gestation, delivered from mothers of all ethnic backgrounds at Meriter Hospital without other known risk factors for IDA.6 (link),10 (link),11 (link)Umbilical blood collected at delivery, stored at 4° C, was assayed within 8 days. Complete blood cell counts were performed by pocH-100i (Sysmex, Mundelein, IL). After washing to remove pigments, cord zinc protoporphyrin/heme (ZnPP/H) was measured with Front-Face Hematofluorometry (Aviv Biomedical Co., Lakewood, NJ).11 (link) Reticulocyteenriched ZnPP/H (RE-ZnPP/H) was measured from the lightest 6.25% of cells to assess ZnPP/H in recently-made erythrocytes.11 (link) Serum ferritin (Bio-Quant, San Diego, CA) was assessed as an index of storage iron and serum transferrin (Immunology Consultants Lab, Newberg, OR) determined as a reflection of transport iron.
The 2 study groups of interest were demarcated as either high-risk (≥3 risk factors) or medium-risk (1-2 risk factors), and compared to the control neonates born to mothers without designated risk factors. Birth weight was z-scored for gestational age, and used to ascertain whether the neonate exceeded the criterion for LGA as >2 or SGA as <−2.10 (link),12 (link) One-way and multiple ANOVA with Fisher post hoc testing were used to compare differences between the groups and the Pearson test was used to evaluate correlations between outcome measures. Chi square analysis was used for nominal demographic variables. The alpha value for statistical significance was set at p<0.05. Natural log conversions were applied to normalize the distribution of ZnPP/H, RE-ZnPP/H and ferritin values. The data portrayed in figures are the mean ± SEM.
The 2 study groups of interest were demarcated as either high-risk (≥3 risk factors) or medium-risk (1-2 risk factors), and compared to the control neonates born to mothers without designated risk factors. Birth weight was z-scored for gestational age, and used to ascertain whether the neonate exceeded the criterion for LGA as >2 or SGA as <−2.10 (link),12 (link) One-way and multiple ANOVA with Fisher post hoc testing were used to compare differences between the groups and the Pearson test was used to evaluate correlations between outcome measures. Chi square analysis was used for nominal demographic variables. The alpha value for statistical significance was set at p<0.05. Natural log conversions were applied to normalize the distribution of ZnPP/H, RE-ZnPP/H and ferritin values. The data portrayed in figures are the mean ± SEM.